News|Articles|December 9, 2024
Recap Key Industry Trends for Viral Clearance and NGS
Author(s)Charles River
Learn highlights from the 2024 event, including new strategies for viral clearance and NGS applications for viral safety testing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5